Lixid 600mg Tablet contains Linezolid, an oxazolidinone-class antibiotic effective against a broad spectrum of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). It is primarily indicated for the treatment of serious bacterial infections such as pneumonia, complicated skin and soft tissue infections, and infections caused by susceptible strains of bacteria where alternative treatments are limited. Linezolid acts by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thereby preventing the formation of the initiation complex essential for bacterial translation. Lixid 600mg is administered orally, with dosing typically adjusted based on the severity and type of infection, as well as patient-specific factors such as renal function. Common adverse effects include gastrointestinal disturbances, headache, and transient hematological abnormalities such as thrombocytopenia, particularly with prolonged use. Caution is advised in patients with a history of myelosuppression or those receiving serotonergic agents due to the risk of serotonin syndrome. Regular monitoring of blood counts is recommended during extended therapy. Lixid 600mg should be used under strict medical supervision to ensure efficacy and minimize the development of antibiotic resistance.